7/30/2008 11:15:54 AM
SEATTLE & ATLANTA--(BUSINESS WIRE)--Regulatory News:
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle’s Swedish Cancer Institute. This revolutionary new technology dramatically decreases treatment times – delivering a higher dose to the tumor target without compromising coverage and patient safety.
comments powered by